Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
The Journal of Pediatrics
|
March 7, 2021
The Use of Economic Evaluation in Pediatric Research
Edward C F Wilson
BMJ (Clinical Research Ed.)
|
October 29, 2005
Trastuzumab for early breast cancer raises important issues
Edward C F Wilson
Applied Health Economics and Health Policy
|
July 14, 2021
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models
Edward C F Wilson
Pharmacoeconomics
|
October 23, 2014
A practical guide to value of information analysis
Edward C F Wilson
Pharmacoeconomics
|
October 13, 2010
Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model
Edward C F Wilson
Applied Health Economics and Health Policy
|
January 1, 2016
The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke's Encephalopathy Presenting at the Emergency Department
Edward C F Wilson, George Stanley, Zulfiquar Mirza
JAMA Dermatology
|
February 21, 2024
Matching Drug Prices to Their Clinical Benefit-The Final Frontier?
Edward C F Wilson, Zenas Z N Yiu
The British Journal of Dermatology
|
June 7, 2026
The US-UK pharmaceutical deal - do dermatologists have skin in the game?
Zenas Z N Yiu, Edward C F Wilson
Health Economics
|
June 19, 2008
Priority setting in practice: what is the best way to compare costs and benefits?
Edward C F Wilson, Stuart J Peacock, Danny Ruta
Cost Effectiveness and Resource Allocation : C/E
|
March 1, 2006
Developing a prioritisation framework in an English Primary Care Trust
Edward C F Wilson, John Rees, Richard J Fordham
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
The Journal of Pediatrics
|
March 7, 2021
The Use of Economic Evaluation in Pediatric Research
Edward C F Wilson
BMJ (Clinical Research Ed.)
|
October 29, 2005
Trastuzumab for early breast cancer raises important issues
Edward C F Wilson
Applied Health Economics and Health Policy
|
July 14, 2021
Methodological Note: Reporting Deterministic versus Probabilistic Results of Markov, Partitioned Survival and Other Non-Linear Models
Edward C F Wilson
Pharmacoeconomics
|
October 23, 2014
A practical guide to value of information analysis
Edward C F Wilson
Pharmacoeconomics
|
October 13, 2010
Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model
Edward C F Wilson
Applied Health Economics and Health Policy
|
January 1, 2016
The Long-Term Cost to the UK NHS and Social Services of Different Durations of IV Thiamine (Vitamin B1) for Chronic Alcohol Misusers with Symptoms of Wernicke's Encephalopathy Presenting at the Emergency Department
Edward C F Wilson, George Stanley, Zulfiquar Mirza
JAMA Dermatology
|
February 21, 2024
Matching Drug Prices to Their Clinical Benefit-The Final Frontier?
Edward C F Wilson, Zenas Z N Yiu
The British Journal of Dermatology
|
June 7, 2026
The US-UK pharmaceutical deal - do dermatologists have skin in the game?
Zenas Z N Yiu, Edward C F Wilson
Health Economics
|
June 19, 2008
Priority setting in practice: what is the best way to compare costs and benefits?
Edward C F Wilson, Stuart J Peacock, Danny Ruta
Cost Effectiveness and Resource Allocation : C/E
|
March 1, 2006
Developing a prioritisation framework in an English Primary Care Trust
Edward C F Wilson, John Rees, Richard J Fordham
Page
of 8